Showing results (151-160 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|April 15, 2004
Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3)Young-Min A Lee, Yunhai Cui, Jörg König, et al.
Pharmacogenetics|April 15, 2004
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomesLeah M Hesse, Ping He, Soundararajan Krishnaswamy, et al.
Pharmacogenetics|April 15, 2004
Analysis of variation in mouse TPMT genotype, expression and activityJames W Watters, Wanghai Zhang, Melissa A Meucci, et al.
Pharmacogenetics|April 15, 2004
Single nucleotide polymorphism characterization by mRNA expression imbalance assessmentLeszek Wojnowski, Jürgen Brockmöller
Pharmacogenetics|December 21, 2004
The human serotonin receptor 2B: coding region polymorphisms and association with vulnerability to illegal drug abuseZhicheng Lin, Donna Walther, Xiao-Ying Yu, et al.
Pharmacogenetics|December 21, 2004
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetesChristelle Foucher, Stephanie Rattier, David M Flavell, et al.
Pharmacogenetics|July 31, 2004
Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liverHugo Girard, Michael H Court, Olivier Bernard, et al.
Pharmacogenetics|July 31, 2004
Discovery of new potentially defective alleles of human CYP2C9Joyce Blaisdell, Lucia F Jorge-Nebert, Sherry Coulter, et al.
Pharmacogenetics|July 31, 2004
Pharmacogenetic roles of CYP2C19 and CYP2B6 in the metabolism of R- and S-mephobarbital in humansKaoru Kobayashi, Jun Morita, Kan Chiba, et al.
Pharmacogenetics|September 30, 2004
Identification and characterization of the FMO2 gene in Rattus norvegicus: a good model to study metabolic and toxicological consequences of the FMO2 polymorphismMarine Hugonnard, Etienne Benoit, Christiane Longin-Sauvageon, et al.
Pageof 83